Is 10x Genomics, Inc. overvalued?

10x Genomics, Inc. (TXG) — key valuation metrics and fundamentals.

No verdict

Price

$85.71

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$10.88B

Dividend yield

0.0%

Return on equity

-9.3%

Sector

Healthcare

Fair value compares TXG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks